Ramon Martin Chavez (born c. 1964) is an American investment banker and entrepreneur.
[10][8] He then joined Credit Suisse Financial Products, where he was the Global Head of Energy Derivatives from 1997 to 2000.
[17] Previously, he served on the board of directors of PNM Resources, Inc., and the International Swaps and Derivatives Association (ISDA).
[18] A passionate patron of the Arts, his board membership includes the Friends of the High Line, the Foundation for AIDS Research, and the Santa Fe Opera.
[19][20][21] Since retiring from Goldman Sachs, Chavez has taken a board observer seat in the early cancer detection and Synthetic Biopsy company Earli, and a Board seat and active role in the AI-driven biomedical technology startup Paige.
[22] He also joined the board of directors Recursion, a digital biology company industrializing drug discovery.
[23] Chavez was elected president of Harvard University's board of overseers for the 2020–21 academic year.